TD Cowen analyst Charles Rhyee lowered the firm’s price target on Cigna (CI) to $333 from $387 and keeps a Buy rating on the shares. The firm updated its estimatesfollowing its Q3 results where it introduced its 2026 framework which calls for adj. EPS growth, EHS seeing a slight decline in adj. pre-tax inc. and CI HC growing at the high end of its LT target growth of 7-10%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI:
- Cigna price target lowered to $330 from $370 at Goldman Sachs
- Cigna’s Strategic Transition and Growth Prospects Justify Buy Rating
- Cigna price target lowered to $350 from $385 at Raymond James
- Cigna price target lowered to $310 from $375 at Truist
- Cigna’s Earnings Call: Strong Performance Amid Challenges